Global syndromic multiplex diagnostic market is projected to register a CAGR of 7.5% in the forecast period of 2020 to 2027. The new market report contains data for historic year 2018, the base year of calculation is 2019 and the forecast period is 2020 to 2027


Market Segmentation:
Global Syndromic Multiplex Diagnostic Market, By Products and Services (Reagents & Consumables, Instruments & Accessories, Software & Services), Infection Type (Viral, Bacterial, Parasites, Fungal and Others), Disease (Respiratory Infections, Gastroenteritis, Sexually Transmitted Infections, Hepatitis, Tropical Fever, Meningitis, Childhood Infections, Immunosuppression and Eye Infections), Panels Type (Respiratory Panel, GI-Enteric Panel, Sexually Transmitted Disease Panel, Blood-Sepsis Panel, Meningitis Panel and Others), End User (Hospitals, Clinical Laboratories, Pharmaceutical & Biotechnology Companies, Research Institutes, Physician Office Lab’s and Others), Country (U.S., Canada, Mexico, Germany, France, U.K., Italy, Spain, Russia, Turkey, Belgium, Netherlands, Switzerland, Rest of Europe, Japan, China, South Korea, India, Australia, Singapore, Thailand, Malaysia, Indonesia, Philippines, Rest of Asia-Pacific, Brazil, Rest of South America, South Africa and Rest of Middle East and Africa) Industry Trends and Forecast to 2027

Some of the major factors contributing to the growth of the global syndromic multiplex diagnostic market are:

- Growing adoption of molecular diagnostics
- Increasing regulatory approval for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) testing

Market Players:

The key market players for global syndromic multiplex diagnostic market are listed below:

- GenMark Diagnostics, Inc.
- QuantuMDx Group Ltd.
- Nan?mix, Inc.
- BioFire Diagnostics (a subsidiary of bioMerieux SA)
- Bio-Rad Laboratories, Inc.
- Thermo Fisher Scientific Inc.
- Siemens Healthcare GmbH
- QIAGEN
- Hologic, Inc.
- F. Hoffmann-La Roche Ltd
- BD
- Danaher
- Prominex
- Curetis
- Applied BioCode, Inc.
- Abbott
- DiaSorin S.p.A.
- Bosch Healthcare Solutions GmbH (a subsidiary of Robert Bosch GmbH)
- Biocartis
- Luminex Corporation
- Seegene Inc.